心房颤动:遗传架构与多基因风险预测
本文综述心房颤动(AF)的遗传架构与多基因风险评分(PGS)研究进展。全基因组关联研究已识别数百个常见变异位点,测序研究将罕见变异与心肌病相关通路联系起来。AF-PGS 对发病、并发症及围术期结局有预测价值,多祖先研究提升了跨人群性能,但临床转化仍面临试验数据有限、祖先代表性不平衡等挑战。
要点
- AF 遗传架构复杂,涉及数百个常见变异位点及心肌病相关通路的罕见变异。
- AF-PGS 对发病、并发症和围术期结局有预测价值,多祖先研究提升跨人群适用性。
- 临床转化受限于试验数据不足、祖先代表性不平衡、表型异质性和评分校准变异。
核心结论
- AF 遗传架构复杂,PGS 是有前景的风险分层工具,但临床转化仍需标准化评估与前瞻性验证。
研究设计与样本
- 综述,总结 AF 遗传学与多基因预测的最新进展。
主要发现
- 全基因组关联研究已识别数百个常见变异位点。
- 测序研究将罕见变异与心肌病相关通路联系起来。
- AF-PGS 对疾病发病、并发症及围术期结局显示预测价值。
- 多祖先研究改善了 AF-PGS 跨人群的性能与通用性。
关键数值与推荐
- AF-PGS 的临床转化面临试验数据仍有限、祖先代表性不平衡、表型异质性和评分校准变异等挑战。
- 将 PGS 与其他分子评分整合可能提升预测准确性。
- 标准化评估指标与前瞻性验证对确立临床效用至关重要。
临床怎么用
- PGS 可用于 AF 风险分层,辅助识别高风险个体以指导个性化预防。
- 临床解读 PGS 时需注意人群祖先差异和评分校准问题。
局限性
- 试验数据仍有限。
- 祖先代表性不平衡。
- 表型异质性。
- 评分校准存在变异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Atrial fibrillation (AF) is a common arrhythmia associated with increased risk of stroke, heart failure and mortality. Advances in genomic research have revealed a complex genetic architecture underlying AF. Genome-wide association studies have identified hundreds of loci of common variants, while sequencing efforts have linked rare variants to cardiomyopathy-related pathways. Polygenic risk scores (PGS) offer a promising tool for AF risk stratification, demonstrating predictive value for disease onset, complications and perioperative outcomes. Multiancestry studies have improved the performance and generalisability of AF-PGS across populations. However, challenges remain in clinical translation, including still limited trial data, unbalanced ancestry representation, phenotype heterogeneity and variability in score calibration. Integration of PGS with other molecular scores may enhance predictive accuracy. Standardised evaluation metrics and prospective validation are essential to establish clinical utility. This review summarises recent advances in AF genetics and polygenic prediction, highlighting opportunities to refine risk assessment and guide personalised prevention strategies in cardiovascular care.
引用
- Yuan, Levin, Larsson, et al. Atrial fibrillation: genetic architecture and polygenic risk prediction. Heart. 2026. PMID: 41802848. doi:10.1136/heartjnl-2025-326870
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。